Differentiation Defect Into GABAergic Neurons in Cerebral Organoids From Autism Patients
CNS Neuroscience & Therapeutics · 2025-06 · 31 (6)
DOI: 10.1111/cns.70449 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 02.06.2025. Verfasst von Sai Hali und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Translational Medicine, School of Medicine, Konkuk University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Organoids, GABAergic Neurons, Cell Differentiation, Autistic Disorder. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Priority Academic Program Development of Jiangsu Higher Education Institutions, Ministry of Health and Welfare of South Korea.
Abstract (Originalsprache)
Objectives
Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects social communication and behaviors. While previous studies using animal models have substantially expanded our knowledge about ASD, the lack of an appropriate human model system that accurately recapitulates the human‐specific pathophysiology of ASD hinders the precise understanding of its etiology and the development of effective therapies. This study aims to replicate pathological phenotypes in cerebral organoids derived from idiopathic ASD patients and to conduct proof‐of‐concept research for the development of ASD therapeutics.
Methods
We conducted an in vitro disease modeling study using cerebral organoids derived from three idiopathic ASD patients. Additionally, we performed organoid‐based phenotypic drug screening to identify potential therapeutic compounds that could ameliorate the phenotypes observed in cerebral organoids derived from idiopathic ASD patients.
Results
Here we show that cerebral organoids derived from idiopathic ASD patients display malformation of the ventricular zones and impaired early neuronal differentiation. Through organoid‐based phenotypic drug screening, we successfully generated cerebral organoids with normal tissue architecture in which the delayed neuronal differentiation could also be accelerated. Notably, cerebral organoids from ASD patients exhibited a reduced number of GABAergic neurons compared to healthy controls, resulting in an imbalance in the excitatory and inhibitory neuron ratio. The differentiation defects into GABAergic neurons in patient‐derived cerebral organoids could be rescued by treating with either IGF1 or Gabapentin, a GABA agonist.
Conclusions
Our findings provide a framework for utilizing patient‐derived cerebral organoids in the development of personalized pharmaceutical treatment for ASD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Advanced Translational Medicine, School of Medicine, Konkuk University, Seoul, Republic of Korea.
- NUOXINTE Biotechnology, Suzhou, China.
- Institute of Neurology, Jiangxi Academy of Clinical Medical Sciences, Department of Neurology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
- Healthcare International Innovation Institute, Jiangmen, China.
- Guangdong University of Technology, Guangzhou, China.
ORCID-Profile: Dong Wook Han
Förderung
- National Research Foundation of Korea
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Ministry of Health and Welfare of South Korea
- National Natural Science Foundation of China
- Government of Shandong Province
Zitieren
APA
Hali, S., Yao, X., Hao, G., Jin, Z. L., Fu, K., Li, Y., Wang, L., Yoo, H., La, H., Park, C., Hong, K., Shin, C. Y., Woo, D. H., Han, C., Jin, X., Zhu, S., Zou, W., Kim, N. H., Kim, K. P., …, & Han, D. W. (2025). Differentiation Defect Into GABAergic Neurons in Cerebral Organoids From Autism Patients. CNS Neuroscience & Therapeutics, 31(6). https://doi.org/10.1111/cns.70449
Vancouver
Hali S, Yao X, Hao G, Jin ZL, Fu K, Li Y, et al. Differentiation Defect Into GABAergic Neurons in Cerebral Organoids From Autism Patients. CNS Neuroscience & Therapeutics. 2025;31(6). doi:10.1111/cns.70449
BibTeX
@article{Hali2025,
author = {Hali, Sai and Yao, Xuerui and Hao, Guo and Jin, Zhe-Long and Fu, Kun and Li, Yunxiao and Wang, Lin and Yoo, Heejeong and La, Hyeonwoo and Park, Chanhyeok and Hong, Kwonho and Shin, Chan Young and Woo, Dong-Hun and Han, Choongseong and Jin, Xiong and Zhu, Shifeng and Zou, Wenquan and Kim, Nam-Hyung and Kim, Kee-Pyo and Zhang, Leshuai W and Han, Dong Wook},
title = {Differentiation Defect Into GABAergic Neurons in Cerebral Organoids From Autism Patients},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {6},
doi = {10.1111/cns.70449}
}
EUVIMED